Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Rangaswamy Govindarajan to Female

This is a "connection" page, showing publications Rangaswamy Govindarajan has written about Female.

 
Connection Strength
 
 
 
0.249
 
  1. Govindarajan R, Gujja S, Siegel ER, Batra A, Saeed A, Lai K, James JD, Fogel BJ, Williamson S. Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer. Am J Clin Oncol. 2018 07; 41(7):638-642.
    View in: PubMed
    Score: 0.040
  2. Govindarajan R, Posey J, Chao CY, Lu R, Jadhav T, Javed AY, Javed A, Mahmoud FA, Osarogiagbon RU, Manne U. A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer. BMC Cancer. 2016 06 18; 16:368.
    View in: PubMed
    Score: 0.035
  3. Kaur H, Sasapu A, Ramos J, Govindarajan R. An Unusual Case of Gastric Cancer with Bone Marrow Metastases and Embolic Phenomena as Initial Presentation. J Gastrointest Cancer. 2015 Dec; 46(4):413-6.
    View in: PubMed
    Score: 0.033
  4. Govindarajan R, Siegel E, Makhoul I, Williamson S. Bevacizumab and erlotinib in previously untreated inoperable and metastatic hepatocellular carcinoma. Am J Clin Oncol. 2013 Jun; 36(3):254-7.
    View in: PubMed
    Score: 0.028
  5. Bansal M, Agarwal A, Bariola R, Aduli F, Govindarajan R. Biliary Actinomycosis Mimicking a Klatskin Tumor. J Gastrointest Cancer. 2012 Sep; 43 Suppl 1:S101-3.
    View in: PubMed
    Score: 0.027
  6. Prasad HK, Govindarajan R. Heparin-induced skin necrosis associated with thrombocytopenia and acquired protein C and protein S deficiency. Am J Hematol. 2007 Dec; 82(12):1116-7.
    View in: PubMed
    Score: 0.019
  7. Govindarajan R, Young JW, Harless CL, Hutchins LF. Barriers to clinical trials vary according to the type of trial and the institution. J Clin Oncol. 2007 Apr 20; 25(12):1633-4; author reply 1634.
    View in: PubMed
    Score: 0.018
  8. Govindarajan R, Adusumilli J, Baxter DL, El-Khoueiry A, Harik SI. Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. J Clin Oncol. 2006 Oct 01; 24(28):e48.
    View in: PubMed
    Score: 0.018
  9. Govindarajan R, Shah RV, Erkman LG, Hutchins LF. Racial differences in the outcome of patients with colorectal carcinoma. Cancer. 2003 Jan 15; 97(2):493-8.
    View in: PubMed
    Score: 0.014
  10. Algazi AP, Othus M, Daud AI, Lo RS, Mehnert JM, Truong TG, Conry R, Kendra K, Doolittle GC, Clark JI, Messino MJ, Moore DF, Lao C, Faller BA, Govindarajan R, Harker-Murray A, Dreisbach L, Moon J, Grossmann KF, Ribas A. Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial. Nat Med. 2020 10; 26(10):1564-1568.
    View in: PubMed
    Score: 0.012
  11. El-Khoueiry AB, Rankin CJ, Ben-Josef E, Lenz HJ, Gold PJ, Hamilton RD, Govindarajan R, Eng C, Blanke CD. SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma. Invest New Drugs. 2012 Aug; 30(4):1646-51.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.